Free Trial

FY2025 EPS Forecast for Cardinal Health Increased by Analyst

Cardinal Health logo with Medical background

Cardinal Health, Inc. (NYSE:CAH - Free Report) - Stock analysts at Leerink Partnrs upped their FY2025 EPS estimates for shares of Cardinal Health in a research note issued on Thursday, June 12th. Leerink Partnrs analyst M. Cherny now expects that the company will earn $8.20 per share for the year, up from their previous forecast of $8.16. The consensus estimate for Cardinal Health's current full-year earnings is $7.95 per share. Leerink Partnrs also issued estimates for Cardinal Health's FY2026 earnings at $9.30 EPS and FY2027 earnings at $10.46 EPS.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Thursday, May 1st. The company reported $2.35 earnings per share for the quarter, topping analysts' consensus estimates of $2.15 by $0.20. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The company had revenue of $54.88 billion during the quarter, compared to the consensus estimate of $55.33 billion. During the same period in the previous year, the firm posted $2.08 earnings per share. The company's revenue was up .0% on a year-over-year basis.

Several other equities analysts have also issued reports on the company. Bank of America upped their price target on Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research note on Tuesday, June 10th. Wells Fargo & Company upgraded shares of Cardinal Health from an "equal weight" rating to an "overweight" rating and upped their target price for the company from $136.00 to $179.00 in a research report on Tuesday, June 3rd. Citigroup raised their target price on shares of Cardinal Health from $157.00 to $170.00 and gave the company a "neutral" rating in a research note on Friday. Mizuho lifted their price target on shares of Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a research report on Monday, March 31st. Finally, Morgan Stanley boosted their price target on shares of Cardinal Health from $166.00 to $181.00 and gave the stock an "overweight" rating in a research note on Friday. Three equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $157.43.

View Our Latest Stock Analysis on Cardinal Health

Cardinal Health Stock Performance

NYSE CAH opened at $161.28 on Monday. The stock has a market capitalization of $38.49 billion, a P/E ratio of 30.09, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. Cardinal Health has a 52 week low of $93.17 and a 52 week high of $162.94. The stock has a fifty day moving average of $146.04 and a 200-day moving average of $132.76.

Hedge Funds Weigh In On Cardinal Health

Several institutional investors and hedge funds have recently made changes to their positions in the company. Pinnacle Bancorp Inc. grew its stake in Cardinal Health by 11.2% in the first quarter. Pinnacle Bancorp Inc. now owns 767 shares of the company's stock valued at $106,000 after acquiring an additional 77 shares during the period. Rothschild Investment LLC lifted its holdings in shares of Cardinal Health by 10.1% during the 4th quarter. Rothschild Investment LLC now owns 858 shares of the company's stock valued at $101,000 after purchasing an additional 79 shares in the last quarter. Applied Finance Capital Management LLC lifted its holdings in shares of Cardinal Health by 1.4% during the 1st quarter. Applied Finance Capital Management LLC now owns 6,049 shares of the company's stock valued at $833,000 after purchasing an additional 85 shares in the last quarter. CSS LLC IL grew its position in shares of Cardinal Health by 0.8% in the 4th quarter. CSS LLC IL now owns 11,190 shares of the company's stock valued at $1,323,000 after purchasing an additional 90 shares during the period. Finally, Perigon Wealth Management LLC increased its stake in Cardinal Health by 4.2% during the 1st quarter. Perigon Wealth Management LLC now owns 2,242 shares of the company's stock worth $309,000 after purchasing an additional 90 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be given a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.27%. This is a boost from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Tuesday, July 1st. Cardinal Health's dividend payout ratio (DPR) is currently 31.83%.

Cardinal Health Company Profile

(Get Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Further Reading

Earnings History and Estimates for Cardinal Health (NYSE:CAH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cardinal Health Right Now?

Before you consider Cardinal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.

While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now
Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines